29/07/2016 15:45:44 1-888-992-3836 (toll free) Free Membership Login

Trinity Biotech News (NASDAQ:TRIB)

DateTimeSource
Headline
07/21/20168:22AMGLOBETrinity Biotech Announces Quarter 2 Financial Results
DUBLIN, Ireland, July 21, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2016. Quarter 2 Results Total revenues for Q2, 2016 were $26.3m... More...>>
07/14/20166:06AMGLOBETrinity Biotech plc to Announce Second Quarter Fiscal Year 2016 Financial Results
DUBLIN, Ireland, July 14, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2016 on Thursday, July 21, 2016. The Company has scheduled... More...>>
05/09/20169:49AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to trade actively in Monday's session are LendingClub Corp. (LC), Krispy Kreme Doughnuts Inc. (KKD), and Freeport-McMoRan Inc. (FCX). LendingClub on Monday said Renaud Laplanche resigned as chief executive and chairman following an internal review of sales of $22 million in... More...>>
04/19/20168:30AMGLOBETrinity Biotech Announces Results for Q1, 2016
DUBLIN, April 19, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2016. Quarter 1 Results Total revenues for Q1, 2016 were $23.5m which compares... More...>>
04/15/20166:57AMGLOBETrinity Biotech plc to Announce First Quarter Fiscal Year 2016 Financial Results
DUBLIN, April 15, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2016 on Tuesday, April 19, 2016. The Company has scheduled a conference... More...>>
03/09/20167:46PMGLOBETrinity Biotech Announces Results for Q4 and Fiscal Year 2015
DUBLIN, March 03, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for fiscal year 2015 and the quarter ended December 31, 2015. The Company also announced that it is suspending... More...>>
03/09/20167:46PMGLOBETrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2015 Financial Results
DUBLIN , Feb. 26, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2015 on Thursday, March 3, 2016. The Company has scheduled... More...>>
12/17/20158:00AMGLOBETrinity Biotech Announces FDA Submission of High Sensitivity Troponin I Product
DUBLIN, Ireland, Dec. 17, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB) is pleased to announce today that it has submitted to the U.S. Food and Drug Administration (FDA), for 510(k) clearance, its Meritas Point of Care Analyzer and Meritas cardiac troponin-I (cTnI) point-of-care assay for use in the diagnosis... More...>>
10/22/20158:36AMGLOBETrinity Biotech Announces Quarter 3 Financial Results
DUBLIN, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2015. Quarter 3 ResultsTotal revenues for Q3, 2015 were $25.8m which... More...>>
10/13/20155:45AMGLOBETrinity Biotech plc to Announce Third Quarter Fiscal Year 2015 Financial Results
DUBLIN, Ireland, Oct. 13, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter fiscal year 2015 on Thursday, October 22, 2015. The Company has scheduled... More...>>
05/04/20156:42PMARNTrinity Biotech plc Stock Rating Upgraded by Zacks (TRIB)
http://www.tickerreport.com/banking-finance/497221/trinity-biotech-plc-stock-rating-upgraded-by-zacks-trib/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/30/20158:23AMGLOBETrinity Biotech Announces Quarter 1 Results -- EPS 17.4 Cents Dividend of 22 Cents
DUBLIN, Ireland, April 30, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2015. Quarter 1 Results Total revenues for Q1, 2015 were $25.2m... More...>>
04/23/20155:13AMGLOBETrinity Biotech plc to Announce First Quarter Fiscal Year 2015 Financial Results
DUBLIN, Ireland, April 23, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2015 on Thursday, April 30, 2015. The Company has scheduled... More...>>
04/09/20151:05PMGLOBETrinity Biotech plc Closes Offering of $115 Million of 4.00% Exchangeable Senior Notes Due 2045, Including Exercise in Full o...
DUBLIN, Ireland, April 9, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced today that Trinity Biotech Investment Limited, its wholly-owned subsidiary (the "Issuer"), closed its offering... More...>>
04/02/20159:04AMPRNUSTrinity Biotech plc Prices Offering of $100 Million of 4.00% Exchangeable Senior Notes due 2045
Trinity Biotech plc Prices Offering of $100 Million of 4.00% Exchangeable Senior Notes due 2045 PR Newswire DUBLIN, April 2, 2015 DUBLIN, April 2, 2015 /PRNewswire/ -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced... More...>>
04/01/20154:16PMPRNUSTrinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045
Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 PR Newswire DUBLIN, April 1, 2015 DUBLIN, April 1, 2015 /PRNewswire/ -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets... More...>>
03/25/201512:21PMGLOBETrinity Biotech Announces Filing of 2014 Annual Report
DUBLIN, March 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it has filed its Form 20-F containing audited consolidated financial statements for the year ended December... More...>>
03/03/20158:47AMGLOBETrinity Biotech Announces Results for Q4 and Fiscal Year 2014
DUBLIN, Ireland, March 3, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for fiscal year 2014 and the quarter ended December 31, 2014. Fiscal year 2014 Results Total revenues... More...>>
02/25/201510:44AMGLOBETrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2014 Financial Results
DUBLIN, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2014 on Tuesday, March 3, 2015. The Company has scheduled a... More...>>
02/23/201510:18AMGLOBETrinity Biotech Announces Recommencement of US Clinical Trials on Its Point-of-Care, High Sensitivity Troponin I Product
DUBLIN, Ireland, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that late last week it shipped Meritas Troponin I product to the USA for the immediate recommencement... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V:us D:20160729 19:45:45